Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-06-18

Clinical Trial Update: Phase I Photodynamic Therapy (PDT) for Benign Dermal Neurofibromas (NF1) [Phase 1]

View source ↗

Summary

Phase I trial of photodynamic therapy for benign dermal neurofibromas in Neurofibromatoses completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Harry T Whelan, MD | Conditions: Neurofibromatoses | Phase 1 | Status: COMPLETED | Results posted: 2021-06-18